Vistra Corp (VST) AI Stock Analysis

Company Guidance

Vistra reaffirmed 2026 guidance of Adjusted EBITDA $6.8B–$7.6B and Adjusted Free Cash Flow before Growth $3.925B–$4.725B and said it is confident of delivering at or above the midpoints; it maintained a 2027 Adjusted EBITDA midpoint opportunity of $7.4B–$7.8B (noting lower ERCOT forwards are partially offset by higher PJM prices, hedges and the nuclear PTC) and said the Cogentrix acquisition and Meta PJM PPA are excluded from that range and could add roughly $700M to the 2027 midpoint. Management expects to generate more than $10B of available cash in 2026–2027, has allocated roughly $3B to shareholders in 2026–2027, retired ~171M shares at an average ~$38/share (returning >$6.5B through Aug 3) with ~$1.2B of repurchase authority remaining (expected to be exhausted by end‑2027), plans $4.5B–$5B of accretive growth spend (Cogentrix, Permian Peakers, PJM nuclear PPA, Oak Hill 2, and a Helix commitment up to $1B, >$500M subject to milestones), and expects about $2B–$2.5B of additional cash to allocate through year‑end 2027 while targeting mid‑teens levered returns and higher credit ratings.